BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 15072180)

  • 1. Does volume perfusion computed tomography enable differentiation of metastatic and non-metastatic mediastinal lymph nodes in lung cancer patients? A feasibility study.
    Spira D; Wecker M; Spira SM; Hetzel J; Spengler W; Sauter A; Horger M
    Cancer Imaging; 2013 Jul; 13(3):323-31. PubMed ID: 23876521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not All That Shines on a PET Scan Is Cancer: A Silicone-Induced Granuloma Masquerading as Malignancy.
    Vedala K; Sobash PT; Johnson D; Kakkera K
    Clin Pract; 2020 Dec; 11(1):8-12. PubMed ID: 33599216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of false-negative and false-positive diagnoses of lymph node metastases in non-small cell lung cancer patients staged by integrated (18F-)fluorodeoxyglucose-positron emission tomography/computed tomography: A retrospective cohort study.
    Kaseda K; Watanabe K; Asakura K; Kazama A; Ozawa Y
    Thorac Cancer; 2016 Jul; 7(4):473-80. PubMed ID: 27385991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.
    Dietrich CF; Annema JT; Clementsen P; Cui XW; Borst MM; Jenssen C
    J Thorac Dis; 2015 Sep; 7(9):E311-25. PubMed ID: 26543620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.
    Cuaron J; Dunphy M; Rimner A
    Front Oncol; 2012; 2():208. PubMed ID: 23316478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.
    Nair-Gill E; Wiltzius SM; Wei XX; Cheng D; Riedinger M; Radu CG; Witte ON
    J Clin Invest; 2010 Jun; 120(6):2005-15. PubMed ID: 20484820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow.
    Kesner AL; Lau VK; Speiser M; Hsueh WA; Agazaryan N; DeMarco JJ; Czernin J; Silverman DH
    J Appl Clin Med Phys; 2008 Jun; 9(3):147-156. PubMed ID: 18716585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
    Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M
    World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.
    Scott WJ; Schwabe JL; Gupta NC; Dewan NA; Reeb SD; Sugimoto JT
    Ann Thorac Surg; 1994 Sep; 58(3):698-703. PubMed ID: 7944691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.
    Shiraki N; Hara M; Ogino H; Shibamoto Y; Iida A; Tamaki T; Murase T; Eimoto T
    Ann Nucl Med; 2004 Feb; 18(1):23-8. PubMed ID: 15072180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
    Chung JH; Cho KJ; Lee SS; Baek HJ; Park JH; Cheon GJ; Choi CW; Lim SM
    J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
    Moloney F; Ryan D; McCarthy L; McCarthy J; Burke L; Henry MT; Kennedy MP; Hinchion J; McSweeney S; Maher MM; O'Regan K
    Eur J Radiol; 2014 May; 83(5):843-7. PubMed ID: 24581594
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.